|
|
||||||||
1The Copenhagen Muscle Research Centre, Human Biology and Nutritional Sciences, University of Guelph, Ontario, Canada; 2Rigshospitalet, University of Copenhagen; and 3The August Krogh Institute, Copenhagen, Denmark
Submitted 4 October 2005 ; accepted in final form 25 January 2006
| ABSTRACT |
|---|
|
|
|---|
30%) thereafter, suggesting that pyruvate availability primarily accounted for reduced carbohydrate oxidation. Increased free fatty acid uptake (P < 0.05) was also associated with decreasing PDH activity (P < 0.05) and increased PDH kinase 4 mRNA (P < 0.05) during exercise and recovery. At 1 h of exercise, pyruvate production was greatest and was closely linked to glutamate, which was the predominant amino acid taken up during exercise and recovery. Alanine and glutamine were also associated with pyruvate metabolism, and they comprised
68% of total amino-acid release during exercise and recovery. Thus reduced pyruvate production was primarily associated with reduced carbohydrate oxidation, whereas the greatest production of pyruvate was related to glutamate, glutamine, and alanine metabolism in early exercise. alanine; pyruvate dehydrogenase kinase 4 mMRNA; carbohydrate oxidation; nitrogen balance
Although reduced carbohydrate oxidation is evident during prolonged exercise, the mechanisms underlying this reduction are unclear since much of our understanding is based on exercise studies lasting up to 90 min. Rarely have there been detailed, quantitative assessments for longer exercise bouts to comprehensively identify regulatory factors involved in substrate utilization. Decreased carbohydrate oxidation has been primarily associated with the decline in muscle glycogen stores (5, 30, 37) and more specifically a decrease in pyruvate dehydrogenase (PDH) activity (37, 38). Watt et al. (38) demonstrated that, at the end of a prolonged exercise bout, PDH kinase (PDK) activity was elevated and coupled with reduced PDH activity in absence of changes in the known modulators (i.e., muscle pyruvate and cellular status) of PDH activity. However, the time course of these alterations remains unknown, which ultimately makes it difficult to further study whether PDH activity specifically regulates carbohydrate oxidation. Because pyruvate is a potent regulator of PDH activity, it is important to examine the amount of pyruvate available for oxidation during exercise. Similarly, investigating the potential adaptive, transcriptional responses of PDK4 to enhanced free fatty acid (FFA) availability, as observed with dietary perturbations and/or exercise, may also provide insightful information on the role of PDH activity in substrate utilization following prolonged exercise (16, 2326, 31).
Although protein and amino acid metabolism may contribute modestly to substrate utilization (20), amino acids such as glutamine and alanine are gluconeogenic precursors that interlink with pyruvate metabolism. Muscle glutamine and alanine are derived from glutamate through different reactions that are coupled with pyruvate metabolism and the tricarboxycylic acid (TCA) cycle. These three amino acids, which demonstrate the most dynamic changes compared with other amino acids during exercise (5, 12, 15, 21, 29), are essential not only to nitrogen balance but also to carbohydrate oxidation. Although glutamine, alanine, and glutamate are important in nitrogen balance and are intimately associated with carbohydrate regulation as well as energy metabolism, there is a limited understanding of amino acid metabolism during prolonged exercise (>60 min) (5, 12, 15, 21, 29).
Thus the present study examined the time course of potential alterations in net pyruvate production in relation to changes in PDH activity as well as carbohydrate oxidation during moderately low-intensity, prolonged exercise. At this intensity, a relevant combination of carbohydrate and fat would be utilized near the onset of exercise, and we anticipated that a decline in carbohydrate oxidation in early exercise would be associated with a decrease in pyruvate availability, which would ultimately reduce PDH activity. The effects of altered FFA metabolism were also examined in association with pyruvate supply and energy provision. Because pyruvate is closely linked to various amino acid reactions, this study also investigated the potential effects of altered pyruvate supply on amino acids, especially glutamine, glutamate, and alanine, that have important implications on gluconeogenesis and nitrogen balance during exercise and in recovery.
| METHODS |
|---|
|
|
|---|
O2) of the subjects was 28 ± 1 yr, 80.0 ± 1.8 kg, and 49.8 ± 1.1 ml·kg1·min1 (3.98 ± 0.10 l/min), respectively. Subjects were informed verbally and in writing of the purpose of the study as well as the procedures and risks involved with the experiment. The experimental protocol was approved by the Copenhagen and Frederiksberg Ethics Committee in Denmark. The study was conducted under the guidelines of the Declaration of Helsinki.
Experimental protocol.
To minimize the variability of food intake, subjects were provided a standardized diet (65% carbohydrate, 15% protein, 20% fat) for the day before testing. After an overnight fast, subjects arrived at the laboratory and rested in the supine position. While resting and before catheterization, pulmonary and blood flow measurements were made. Arterial blood flow was measured at rest and recovery using ultrasound Doppler, as described by Rådegran et al. (28), and was estimated during exercise using measured femoral arteriovenous oxygen differences and rate of pulmonary
O2 at a given workload according to Fick's principle (33). Cannulation of the femoral artery and vein was performed under local anesthesia. The femoral arterial catheter was inserted
2 cm below the inguinal ligament and set proximally
10 cm, whereas the femoral venous catheter was placed
25 cm below the inguinal ligament and forwarded
10 cm in the distal direction. After the insertion of the catheters, subjects rested for 20 min before resting blood samples were drawn. Subsequently, a biopsy was obtained from the vastus lateralis muscle under local anesthesia using the needle biopsy technique as described by Bergström (4).
Following the preparatory procedures and the resting measurements, subjects cycled at 44 ± 1% maximal
O2 (mean ± SE) with a cadence of 70 rpm until exhaustion. This exercise intensity was chosen so that subjects could maintain steady-state exercise for a prolonged time period to allow for the evaluation of changes in substrate utilization. Pulmonary measurements were taken 30 min into the exercise protocol. Thereafter, pulmonary measurements as well as blood and muscle samples were obtained at hourly intervals. When subjects could not maintain 70 rpm for longer than 30 s, this was denoted as exhaustion, at which point they stopped exercising and a muscle biopsy was taken immediately. The subjects remained in the supine position and refrained from eating during the following 3 h of recovery. Pulmonary and blood flow measurements as well as blood samples were taken hourly, whereas muscle biopsies were obtained at 1 and 3 h postexercise.
Blood analysis. Heparinized syringes were used to collect blood samples for measuring blood PCO2 and PO2 (ABL5, Radiometer), hemoglobin, oxygen saturation (OSM3 hemoximeter, Radiometer), and hematocrit. Arterial and venous plasma samples from the heparinized syringes were used to analyze amino acids using ultraviolet detection on high-performance liquid chromotography (14) and ammonia using a fluorometric method (3). Arterial blood samples were collected in tubes containing EDTA and glutathione, which were centrifuged and plasma stored at 40°C for the analysis of insulin (DAKO), glucagon (Linco Research), and catecholamines. Catecholamines were analyzed using high-performance liquid chromotography with electrochemical detection as described by Hallman et al. (13). Arterial and venous samples were collected for the analysis of glucose, lactate, and FFAs, whereby blood glucose and lactate were measured on an automatic analyzer (EML105, Radiometer) and plasma lactate and glucose were analyzed with an enzymatic method on an automatic analyzer (Cobas Fara, Roche). Plasma FFAs were measured using a WAKO NEFA-C kit (Wako Chemical).
Muscle analysis. Biopsy samples were immediately frozen (<10 s) and stored in liquid nitrogen. A 10- to 20-mg piece of muscle sample was used to measure PDH activity (6, 8) as modified by Putman et al. (27). These data were corrected for differences in blood and connective tissue by adjusting, within a subject, to the highest total creatine concentration in the neutralized perchloric acid extracts of wet muscle homogenates used for the PDH activity analyses. Another part of the biopsy sample was freeze-dried, powdered, and stored at 80°C. The freeze-dried muscle was then extracted using 0.5 M perchloric acid (with 1 mM EDTA) and neutralized with 2.2 M KHCO3. The extract was then used to measure muscle amino acids (14), glycogen (22), pyruvate (22), and acetyl-CoA (6). Adenine nucleotides, phosphocreatine, and creatine were also measured and are presented elsewhere (39).
RNA isolation, reverse transcription, and PCR.
Total RNA was isolated from
25 mg of tissue by a modified guanidinium thiocyanate-phenol-chloroform extraction method adapted from Chomczynski and Sacchi (7) and as described previously (26). RNA was resuspended overnight (4°C) in 2 µl/mg muscle tissue in DEPC-treated H2O containing 0.1 mM EDTA. Reverse transcription of 11 µl of total RNA sample was performed using the Superscript II RNase H system (Invitrogen) as previously described (26). Reverse transcription products were diluted in nuclease-free H2O to a total volume of 150 µl. The mRNA content of the PDK4 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; used as endogenous control) genes was determined by real-time PCR (ABI PRISM 7700 sequence detection system, Applied Biosystems). The following oligonucleotides were designed from human-specific sequence database (Entrez-NIH) using computer software (Primer Express, Applied Biosystems) to amplify a fragment of the PDK4 gene: forward primer 5'-TCCACTGCACCAACGCCT-3'; reverse primer 5'-TGGCAAGCCGTAACCAAAA-3' and TaqMan probe 5'-ATAATTCCCGGAATGCTCCTTTGGCTG-3'. The probe was 5' 6-carboxyfluorescein and 3' 6-carboxy-N,N,N',N'-tetramethylrhodamine labeled. Prior optimization was conducted determining optimal primer and probe concentrations and verifying the efficiency of the amplification. The expected size of the PCR product was initially confirmed by gel electrophoresis (2.5% agarose gel) as part of the pretesting. GAPDH was amplified using a predeveloped assay reagent (Applied Biosystems). PCR amplification was performed (in triplicate) in a total reaction volume of 25 µl. The reaction mixture consisted of 2.5 µl of diluted template, forward and reverse primers and probe as determined from the prior optimization, x2 TaqMan Universal MasterMix optimized for TaqMan reactions (Applied Biosystems; containing AmpliTaq Gold DNA polymerase, AmpErase uracil NH2-glycosylase, 2-deoxynucleotide 5'-triphosphate with dUTP, ROX as passive reference, and buffer components) and nuclease-free water. The following cycle profile was used for both genes: 50°C for 2 min + 95°C for 10 min + (95°C for 15 s + 60°C for 1 min) x 40 cycles. For each gene, the threshold cycle (the cycle number where the amplification curve crosses a defined fluorescence threshold) was determined for each sample and converted to a (relative) PDK4 mRNA amount and GAPDH amount, respectively, by using a standard curve constructed from the results of a serial dilution of a representative sample run together with the unknown samples. The amount of PDK4 was normalized to the amount of GAPDH for each sample.
Statistics and calculations. Values are expressed as means ± SE. All data were analyzed using one-way repeated-measures ANOVA, and Tukey's post hoc analysis was used. Statistical significance was accepted at P < 0.05. Statistical analyses of mRNA expression was performed on logarithmic transformed ratios (PDK4/GAPDH), and these data are presented as fold change relative to preexercise values. All uptake calculations were based on the Fick principle, and hematocrit data were used when plasma flow data were required. The term "flux" is used interchangeable with "net flux," and they maintain the same meaning.
Energy (kcal) use from fat and carbohydrate sources, excluding protein oxidation, during prolonged exercise was calculated by assuming that only the exercising legs expended energy [i.e., respiratory exchange ratio (RER) = respiratory quotient] (9). The energy sources that were calculated included whole body carbohydrate oxidation, blood glucose uptake by the leg, estimated muscle glycogen use, whole body fat utilization, blood FFA uptake by the leg, as well as estimated intramuscular triglyceride utilization. Whole body carbohydrate and fat utilization rates were calculated using pulmonary RER and
O2, whereas muscle carbohydrate and fat utilization were calculated using leg
O2, assuming RER is the same as leg respiratory quotient (18). Blood glucose uptake (mmol·min1·leg1) was multiplied by the appropriate exercise time (for each subject) and then converted to grams per leg by multiplying the molecular weight of glucose (180 g/mmol) and then to calories per gram of carbohydrate (
4.2 kcal/g) for resulting calculations to be in kilocalories per leg. These results were multiplied by 2 to represent both legs. From this information, pyruvate oxidized was calculated. Thus the amount of pyruvate produced was calculated by adding net lactate efflux, net alanine production, and changes in muscle pyruvate concentrations to the amount of pyruvate oxidized. The same calculations were used for FFA uptake except that molecular mass of palmytoyl-stearoyl-oleoyl-glycerol was used (861 g), which accounts for a combination of fatty acids as suggested by Frayn (9). Subsequently, this was multiplied by calories per gram of fat (9.5 kcal/g). The use of intramuscular triacylglycerol (IMTG) and glycogen was derived by calculating total calories of fat and carbohydrates used, respectively, and subtracting blood glucose and FFAs from the total use, respectively. Finally, to present data in per kilogram muscle (dry weight), leg muscle mass was assumed to be 8 kg wet wt or
2 kg dry wt.
Branched-chain amino acids (BCAA) were calculated as the sum of valine, leucine, and isoleucine. The sum of threonine, methionine, phenylalanine, lysine, and BCAA was referred to as total essential amino acids. Due to its importance in protein metabolism, tyrosine was also added to the list of amino acids that were presented. Total amino acids (TAA) were calculated as the sum of all amino acids measured, which included essential amino acids, tyrosine, aspartate, serine, asparagine, glycine, taurine, histidine, ariginine, proline, and ornithine. Net exchange of specific amino acids was calculated as the sum of delta muscle concentrations between two time points and the net total amount released or taken over the given period of time. Despite the fact that glutamine consists of two amino groups, net exchange of glutamine was assumed to represent one amino group because the source of the second amino group could not be determined, since it can arise from either glutamate (2 amino groups) or protein degradation (1 amino group).
| RESULTS |
|---|
|
|
|---|
O2, RER, blood flow, and leg
O2.
Subjects exercised at
44% maximal
O2 for 3 h 23 min ± 11 min. As expected, pulmonary and leg
O2 as well as leg blood flow were elevated (P < 0.05) for the entire exercise duration (Table 1), and leg
O2 comprised
80% of pulmonary
O2. RER peaked at 30 min and declined
13% during exercise (P < 0.05; Table 1), reflecting a decrease in carbohydrate oxidation and a reciprocal increase in fat oxidation (Fig. 1). After 1 h of exercise, contributions from muscle glycogen began to decline (Fig. 1), whereas those from blood glucose uptake remained constant. As exercise progressed, more energy was derived from circulating FFA than IMTG. During the first 2 h of recovery, leg
O2 returned to resting values, whereas pulmonary
O2 remained elevated (P > 0.05) by
50 ml O2/min compared with rest, which suggests that extramuscular processes may be important in reestablishing energy homeostasis.
|
|
3.7-fold at 1 h of exercise compared with rest (P < 0.05) and reached peak values at 2 h of exercise. Thereafter, PDHa exhibited
30% decrease at 3 h (P = 0.16) and exhaustion (P < 0.05) compared with 1 h, and further declined during recovery (P < 0.05; Fig. 2). Despite that muscle pyruvate and acetyl-CoA concentrations were unaltered during exercise and recovery (Table 2), net pyruvate production dropped by
30% (from
27 to 19 mmol·kg dry wt1·h1) from 1 to 3 h of exercise, suggesting that pyruvate availability, not PDH activity, was associated with reduced carbohydrate oxidation. PDK4 mRNA was significantly elevated at 3 h of exercise and for the remainder of the protocol, but PDK4 mRNA exhibited a pronounced increase (
7- to 9-fold) in recovery compared with rest (Fig. 3). This increase in PDK4 mRNA suggests specific regulation of the PDK4 gene with prolonged exercise.
|
|
|
|
|
Amino acid and ammonia data.
During exercise, alanine and glutamine release rates were both elevated
8- to 11-fold from rest and returned to resting rates during recovery (Table 4; P > 0.05) with only modest alterations in muscle concentrations (Table 5). Net exchange of glutamine and alanine dropped (
67%) during the first hour of exercise from
14 to 5.8 mmol/kg dry wt (P > 0.05) and
4.3 to 1.5 mmol/kg dry wt (P = 0.15), respectively. Arterial alanine and glutamine were elevated (
47 and
17%, respectively) in the first 2 h of exercise, coinciding with the net muscle release, and subsequently declined by 3 h (P < 0.05; Table 4), indicating that they were cleared by extramuscular tissues.
|
|
31% at 1 h of exercise compared with rest (12.50 ± 0.89 to 8.72 ± 1.64 mmol/kg dry wt; P > 0.05) and maintained these levels for the remainder of exercise and recovery. Glutamate uptake increased approximately fourfold from rest to 1 h of exercise and was accompanied by an
40% (9 µM) decrease in arterial glutamate in the first hour of exercise (P < 0.05). Arterial glutamate remained at this concentration and did not return to rest levels during recovery (Table 4). Total glutamate uptake of
0.3 mmol/kg dry wt in the first hour of exercise was insufficient to restore the initial
4 mmol/kg dry wt drop in muscle glutamate (net glutamate consumption = 4.3 mmol·kg dry wt1·h1; P < 0.05). Net consumption was subsequently reduced to
1.2 mmol·kg dry wt1·h1 at 2 h of exercise. Although glutamate delivery to the leg and the circulation-to-muscle gradient were constant, the reduced glutamate net exchange at 2 h suggested that glutamate transport was regulated during exercise.
Despite that alanine, glutamine, glutamate, and BCAA represent more than 50% of the free amino acid pool in muscle, their intramuscular concentrations were minimally altered even with continual exchange between muscle and circulation (Table 5). In early exercise, the majority of arterial amino acid concentrations were modestly elevated from rest concentrations, but most of these amino acids returned to resting levels by 3 h of exercise, and arterial TAA were further reduced during recovery (Table 5; P < 0.05). Arterial tyrosine and phenylalanine were elevated at exhaustion, suggesting potential net protein degradation. Net nitrogen balance was also influenced by constant ammonia release during exercise, which was reversed to muscle uptake during recovery (Table 3). Collectively, glutamine, alanine, BCAA, and ammonia demonstrated a relatively large nitrogen release from the muscle (
36 mmol/leg), whereas little nitrogen (primarily glutamate) was taken up (
1.6 mmol/leg) during exercise (Fig. 5). During recovery, glutamine, alanine, and BCAA continued to be released (
6.5 mmol/leg), whereas minimal nitrogen was recovered by glutamate and ammonia uptake (
1.1 mmol/leg).
|
| DISCUSSION |
|---|
|
|
|---|
Integration of carbohydrate, fat, and amino acid metabolism in substrate oxidation. Carbohydrate oxidation peaked at 30 min of exercise and subsequently declined for the remainder of exercise, whereas PDH activity peaked at 2 h of exercise. This uncoupling between carbohydrate oxidation and PDH activity suggests that PDH activity was not regulating the changes in carbohydrate oxidation; rather, reduced carbohydrate oxidation and subsequently PDH activity were likely attributed to decreased pyruvate production, which occurred after 1 h of exercise, independent of changes in muscle pyruvate concentrations. Watt et al. (37, 38) previously suggested that a decrease in RER at the end of a prolonged exercise bout was related to lower PDH activity as a result of elevated PDK activity. However, examining PDH activity and its association with RER at the end of exercise is inappropriate, since RER is known to decline in early exercise. The present study was specifically designed to examine the time course of relevant factors involved in reduced carbohydrate oxidation during prolonged exercise to provide a strong basis for future investigations. With additional time points and the inclusion of flux measurements across the exercising leg, we calculated pyruvate production rate and coupled these changes with carbohydrate oxidation and PDH activity. Although the attenuated rate of pyruvate production was likely to be the key contributing factor to lower carbohydrate oxidation, and subsequently reduced PDH activity, future work is needed to directly investigate the effects of pyruvate availability on carbohydrate oxidation.
The lack of change in the known modulators of PDH activity indicates that they were unlikely to have a major role in PDH regulation. Although PDH phosphatase may be important in the activation of PDH activity at the onset of exercise (17), PDK activity is essential in its downregulation during prolonged exercise (38). However, PDK activity is modulated by changes in pyruvate concentrations and/or cellular energy status, whereby not only was intramuscular pyruvate concentration unaltered in the present study but our laboratory has also shown that adenine nucleotide content as well as ATP-to-ADP ratios were unchanged during prolonged exercise (39). The net production of pyruvate declined from
27 mmol/kg dry wt in hour 1 of exercise to
19 mmol/kg dry wt in hour 3 and would have resulted from decreased muscle glycogenolysis, glycolysis, and/or glucose uptake. Muscle glucose uptake was maintained during exercise despite the decrease in arterial glucose, whereas decreased reliance on glycogenolysis (Fig. 1) as well as regulatory factors of glycolytic rate may have been coupled with changes in pyruvate production rate. Although future work is warranted, reduced net pyruvate production was likely modulated by regulatory factors of glycogenolysis and glycolysis, which contributed to decreasing carbohydrate oxidation and subsequently reduced PDH activity.
Despite the decrease in pyruvate supply, energy provision to the working muscles was maintained since TCA cycle flux (i.e., leg
O2) was constant. Continual energy provision was exhibited with the significant rise in FFA uptake by muscle, which may have also been associated with decreased PDH activity. In addition, enhanced FFA supply may have instigated a rise in PDK4 mRNA by 3 h of exercise, since it has been suggested in previous work that elevated FFA supply is associated with increased PDK4 gene expression in skeletal muscle (16, 23, 24, 31). Because these transcriptional increases were more pronounced in recovery, which is consistent with previous work (25, 26), they may be indicative of specific adaptive responses associated with prolonged exercise. With a growing reliance on energy derived from FFA uptake, the contracting muscle relied less on IMTG and muscle glycogen as exercise progressed. Enhanced plasma FFA availability was derived from activated lipolysis in adipose tissue as a result of reduced insulin and elevated catecholamine levels and was associated with elevated fat oxidation. Glucose uptake was elevated during exercise, suggesting that a continual reliance on blood-borne glucose for energy was evident. Increased glucagon levels helped to maintain arterial glucose concentrations by activating gluconeogenesis in extramuscular tissues. Thus various tissues integrated diverse signals to facilitate energy provision from carbohydrates and fats for the exercising muscles to accommodate the decrease in net muscle pyruvate production.
Although decreased pyruvate supply resulted in reduced PDH activity, lactate dehydrogenase and alanine aminotransferase, which are near-equilibrium enzymes that also utilize pyruvate as a substrate, were affected differently. Changes in lactate efflux were modest and may have been more important in early exercise (<60 min) when pyruvate production was greatest. In contrast, alanine release from muscle was elevated 8- to 11-fold compared with rest despite that skeletal muscle concentrations were maintained at constant levels. Peak pyruvate production during early exercise coincided with alanine release, and, subsequently, as pyruvate production decreased, alanine release remained constant. It is possible that, since alanine is a gluconeogenic precursor, its constant release may have helped to maintain arterial glucose and to support constant glucose uptake in muscle during the latter phase of exercise. Furthermore, arterial alanine was significantly elevated in early exercise and was reduced to resting levels by 3 h of exercise despite elevated release from the muscle, implying that alanine was cleared by other tissues, presumably the liver. Thus the continuous supply of pyruvate for alanine production suggests an important role for alanine, likely gluconeogenesis, during the latter part of prolonged exercise.
Alanine is intimately coupled with glutamine and glutamate metabolism through the TCA cycle, indicating that other amino acids are associated with pyruvate metabolism. The largest production of glutamine and alanine (
14 and 4.3 mmol/kg dry wt, respectively) and glutamate utilization (
4.1 mmol/kg dry wt) occurred in the first hour of exercise when pyruvate production was greatest (
27 mmol/kg dry wt). Glutamate, alanine, and glutamine net exchanges were subsequently reduced (85, 56, and 54%, respectively) from 1 to 2 h of exercise, suggesting that these amino acids were most dynamic in the first hour of exercise. The potential importance of alanine in early exercise is supported by observations from Gibala et al. (10, 11), where muscle pyruvate and alanine concentrations as well as alanine flux were elevated as early as 5 min of exercise. Thus these data indicate that glutamate, glutamine, and alanine are distinctly linked to pyruvate metabolism and may be important in early exercise regulation.
In addition to pyruvate metabolism, glutamate, glutamine, and alanine had large implications on nitrogen balance during prolonged exercise. Previous work has shown that glutamine, alanine, and BCAA are the predominant amino acids released from muscle during 6090 min of exercise (5, 10, 21, 32). In the present study,
36 mmol/leg were released collectively in the form of glutamine, alanine, BCAA, and ammonia during low-intensity exercise, where glutamine and alanine alone represented
68% of TAA released. With only 1.6 mmol/leg of glutamate taken up during exercise (Fig. 5), the interactions between glutamate, glutamine, alanine, as well as BCAA, reflect the importance of these amino acids in nitrogen and energy balance of exercising muscles. The net release of threonine, tyrosine, methionine, and lysine were elevated throughout exercise, possibly representing continuous muscle protein degradation. Previous studies of shorter exercise duration have reported enhanced release of various amino acids by muscle and corresponding decreases in plasma concentrations (15, 32, 35). As such, the interactions between glutamine, alanine, and glutamate revealed the importance of the these amino acids in both pyruvate metabolism and nitrogen balance in muscle.
Reestablishing homeostasis in the recovery period.
During recovery, protein degradation continued with the net release of threonine, tyrosine, methionine, and lysine from muscle, which were likely important in reestablishing homeostasis in extramuscular tissues. Greater efflux was evidenced with BCAA, glutamine, and alanine (
6.5 mmol/leg combined), which comprised
67% of TAA released over the 3-h recovery period. Moreover, nitrogen uptake was only 1.1 mmol/leg (glutamate and ammonia) during the 3-h recovery period. These particular amino acids may have been important to various recovery processes by enhancing protein production and gluconeogenesis in extramuscular tissues. The importance of gluconeogenic amino acids was evident since arterial glucose returned to resting levels by the end of the recovery period. In agreement with previous work (2), the trend in elevated postexercise pulmonary
O2 (
50 ml O2/min), which was 18% greater than preexercise values despite that leg
O2 had returned to resting rates, was potentially important in reestablishing homeostasis during recovery. Changes in fat metabolism also suggested a potential role in recovering energy homeostasis because estimated use of IMTG was modestly elevated during recovery as was PDK4 mRNA; these metabolic events may be linked to the further decline in PDH activity during recovery. Kimber et al. (19) demonstrated that, following glycogen-depleting exercise, the circulating fatty acids and triacylglycerol were the primary lipid sources since IMTG levels remained unaltered following 18 h of recovery. However, IMTG use may be somewhat lower than in the present study since subjects in the work of Kimber et al. were fed a high-carbohydrate/low-fat meal following exercise, which may have led to decreased IMTG reliance. Overall, these relationships likely facilitated the attenuation of carbohydrate utilization to enable glycogen resynthesis, potentially demonstrating an acute adaptive response to prolonged exercise. Thus these data illustrate the dynamic relationship between amino acid, carbohydrate, and fat metabolism within muscle and across extramuscular tissues during recovery.
Methodological considerations. Although the techniques and protocol used in this study provided a comprehensive approach to further understanding the regulation of substrate metabolism during prolonged exercise, there are certain factors that should be considered. One must consider that the information attained is descriptive in nature and that future mechanistic studies are needed to further understand substrate regulation in prolonged exercise. Due to the invasive nature of the study, the sample size that was studied warrants careful interpretation of the results presented. Subjects were also studied following an overnight fast, which may have implications on protein degradation and carbohydrate metabolism. However, the introduction of food would confound the results of this study, since many of the parameters measured are highly sensitive to different types of foods (i.e., high- vs. low-carbohydrate meal). For the purpose of this study, nutritional intake before and after exercise was restricted since we were interested in demonstrating regulatory changes in substrate utilization from carbohydrate to fat metabolism during prolonged exercise. Feeding subjects before exercise would exaggerate interindividual variability since the amount of time required to cannulate the femoral artery and vein for each subject before commencing the exercise protocol varies; this could not have been controlled adequately, which would have greater implications on our results.
In summary, decreased carbohydrate oxidation during prolonged exercise was associated with a reduced PDH activity and was attributed to a reduced rate of pyruvate production. None of the known modulators of PDH activity were altered, implying that glycogenolytic and glycolytic regulatory factors may have induced a decrease in carbohydrate oxidation. Increased FFA supply not only provided energy to the exercising muscle but may also have been related to the increased PDK4 mRNA, particularly during recovery, indicating an adaptive response to prolonged exercise. Despite that reduced pyruvate production resulted in lower PDH activity, production of gluconeogenic precursors (alanine and glutamine) was maintained. Pyruvate metabolism was also integrated with other amino acids, such as glutamate and glutamine, in early exercise, which was particularly interesting because these amino acids (alanine, glutamate, and glutamine) demonstrated the most pronounced effects on nitrogen balance.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
phosphorylation in human muscle during prolonged exercise. Biochem Biophys Res Commun 298: 309316, 2002.[CrossRef][Web of Science][Medline]This article has been cited by other articles:
![]() |
K. Kiilerich, J. B. Birk, R. Damsgaard, J. F. P. Wojtaszewski, and H. Pilegaard Regulation of PDH in human arm and leg muscles at rest and during intense exercise Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E36 - E42. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Wende, P. J. Schaeffer, G. J. Parker, C. Zechner, D.-H. Han, M. M. Chen, C. R. Hancock, J. J. Lehman, J. M. Huss, D. A. McClain, et al. A Role for the Transcriptional Coactivator PGC-1{alpha} in Muscle Refueling J. Biol. Chem., December 14, 2007; 282(50): 36642 - 36651. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Klein, H. Pilegaard, J. T. Treebak, T. E. Jensen, B. Viollet, P. Schjerling, and J. F. P. Wojtaszewski Lack of AMPK{alpha}2 enhances pyruvate dehydrogenase activity during exercise Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1242 - E1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pilegaard, J. B. Birk, M. Sacchetti, M. Mourtzakis, D. G. Hardie, G. Stewart, P. D. Neufer, B. Saltin, G. van Hall, and J. F.P. Wojtaszewski PDH-E1{alpha} Dephosphorylation and Activation in Human Skeletal Muscle During Exercise: Effect of Intralipid Infusion Diabetes, November 1, 2006; 55(11): 3020 - 3027. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |